These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2941 related items for PubMed ID: 26345332

  • 1. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V, de Lutio di Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R, Izzo F, Gallipoli AD, Petrillo A.
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.
    Granata V, Fusco R, Catalano O, Piccirillo M, De Bellis M, Izzo F, Petrillo A.
    AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934
    [Abstract] [Full Text] [Related]

  • 3. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
    Sugimoto K, Moriyasu F, Saito K, Kobayashi Y, Itoi T.
    J Med Ultrason (2001); 2017 Jul; 44(3):247-254. PubMed ID: 27933441
    [Abstract] [Full Text] [Related]

  • 4. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O, Izzo F, Vallone P, Sandomenico F, Albino V, Nunziata A, Fusco R, Petrillo A.
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [Abstract] [Full Text] [Related]

  • 5. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY, Luo Y, Wen TF, Jiang L, Li C, Zhong XF, Zhang JY, Ling WW, Yan LN, Zeng Y, Wu H.
    World J Gastroenterol; 2014 Sep 21; 20(35):12628-36. PubMed ID: 25253968
    [Abstract] [Full Text] [Related]

  • 6. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ, Rennert J, Schacherer D, Girlich C, Hoffstetter P, Heiss P, Jung W, Feuerbach S, Zorger N, Jung EM.
    Clin Hemorheol Microcirc; 2010 Sep 21; 46(2-3):101-15. PubMed ID: 21135486
    [Abstract] [Full Text] [Related]

  • 7. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec 21; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
    Kobayashi T, Aikata H, Hatooka M, Morio K, Morio R, Kan H, Fujino H, Fukuhara T, Masaki K, Ohno A, Naeshiro N, Nakahara T, Honda Y, Murakami E, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Takahashi S, Chayama K.
    Eur Radiol; 2015 Nov 21; 25(11):3272-81. PubMed ID: 26037713
    [Abstract] [Full Text] [Related]

  • 9. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.
    Sugimori K, Numata K, Okada M, Nihonmatsu H, Takebayashi S, Maeda S, Nakano M, Tanaka K.
    J Med Ultrason (2001); 2017 Jan 21; 44(1):89-100. PubMed ID: 27771842
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
    Maiwald B, Lobsien D, Kahn T, Stumpp P.
    PLoS One; 2014 Jan 21; 9(11):e111935. PubMed ID: 25375778
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.
    Invest Radiol; 2010 Mar 21; 45(3):133-41. PubMed ID: 20098330
    [Abstract] [Full Text] [Related]

  • 15. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.
    Bartolotta TV, Taibbi A, Matranga D, Midiri M, Lagalla R.
    Radiol Med; 2015 Aug 21; 120(8):695-704. PubMed ID: 25698299
    [Abstract] [Full Text] [Related]

  • 16. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B, Wildner D, Pfeifer L, Goertz RS, Hagel A, Neurath MF, Strobel D.
    Ultraschall Med; 2016 Dec 21; 37(6):627-634. PubMed ID: 27486793
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    Granata V, Fusco R, Catalano O, Avallone A, Palaia R, Botti G, Tatangelo F, Granata F, Cascella M, Izzo F, Petrillo A.
    PLoS One; 2017 Dec 21; 12(6):e0179951. PubMed ID: 28632786
    [Abstract] [Full Text] [Related]

  • 18. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C, Goertz RS, Strobel D, Lell M, Neurath MF, Knieling F, Scharf M.
    Ultraschall Med; 2012 Dec 21; 33(6):587-92. PubMed ID: 23154871
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B, Görtz RS, Pfeifer L, Kielisch C, Neurath MF, Strobel D.
    Eur J Gastroenterol Hepatol; 2017 Sep 21; 29(9):1036-1044. PubMed ID: 28562394
    [Abstract] [Full Text] [Related]

  • 20. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov 21; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 148.